The Global Telmisartan Market is expected to be around US$ 4.50 Billion by 2028 at a CAGR of 1.75% in the given forecast period.
Telmisartan is a physician endorsed prescription regularly recommended to unwind and broaden veins in people with hypertension. Telmisartan has a place with a gathering of medications called angiotensin II receptor blockers (ARBs). Telmisartan might be utilized alone or in mix with different drugs, for example, hydrochlorothiazide for treatment of hypertension. Telmisartan likewise has its symptoms that incorporate tipsiness, dizziness, hack, sinus torment, and others.
Rising endorsements for Abbreviated new Drug Application (ANDA) for delivering conventional telmisartan tablets is and growing awareness and knowledge with respect to hypertension and its administration by arranging worldwide campaigns are relied upon to drive the growth of the market comprehensively. The pervasiveness of hypertension is expanding internationally ascribed to the rising geriatric populace, changing lifestyles and chronic disorders such as cardiovascular diseases, diabetes which in turn is expected to increase the demand for telmisartan market globally.
The global Telmisartan market is segregated on the basis of Product as Injection and Freeze-Dried Powder. Based on End User the global Telmisartan market is segmented in Hospital Use and Clinic Use.
The global Telmisartan market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Telmisartan market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy’s Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer, GSK, Astellas Pharma Inc, and others are among the major players in the global Telmisartan market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Telmisartan Market has been segmented as below:
Telmisartan Market, By Product
Telmisartan Market, By End User
Telmisartan Market, By Region
Telmisartan Market, By Company
The report covers:
Report Scope:
The global Telmisartan market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Telmisartan market share. Major industry players with significant revenue share include Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy’s Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer, GSK, Astellas Pharma Inc, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Kitasamycin (CAS 69-23-8) Market
Josamycin (CAS 16846-24-5) Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Telmisartan Market, By Product
5.1 Introduction
5.2 Injection
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Freeze-Dried Powder
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Telmisartan Market, By End User
6.1 Introduction
6.2 Hospital Use
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Clinic Use
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Telmisartan Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Telmisartan, By Product
7.2.2 North America Telmisartan, By End User
7.3 Europe
7.3.1 Europe Telmisartan, By Product
7.3.2 Europe Telmisartan, By End User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Telmisartan, By Product
7.4.2 Asia-Pacific Telmisartan, By End User
7.5 Rest of the World
7.5.1 Rest of the World Telmisartan, By Product
7.5.2 Rest of the World Telmisartan, By End User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Pfizer
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Teva
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Novartis
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Mylan
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Reddy’s Laboratories (UK)
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Hema Pharmaceuticals Pvt
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.7 Bayer
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 GSK
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Astellas Pharma Inc
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
The Telmisartan Market has been segmented as below:
Telmisartan Market, By Product
Telmisartan Market, By End User
Telmisartan Market, By Region
Telmisartan Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
